BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20417220)

  • 1. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
    Laaris N; Good CH; Lupica CR
    Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
    Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
    Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
    Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
    Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
    Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
    Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortical distribution of muscarinic M2 and cannabinoid-1 (CB1) receptors in adult male mice with or without chronic adolescent exposure to Δ9-tetrahydrocannabinol.
    Garzón M; Chan J; Mackie K; Pickel VM
    Cereb Cortex; 2022 Nov; 32(23):5420-5437. PubMed ID: 35151230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
    Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
    J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity.
    Fan N; Yang H; Zhang J; Chen C
    J Neurochem; 2010 Feb; 112(3):691-702. PubMed ID: 19912468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats.
    Kang-Park MH; Wilson WA; Kuhn CM; Moore SD; Swartzwelder HS
    J Neurophysiol; 2007 Sep; 98(3):1223-30. PubMed ID: 17634345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.
    Sidló Z; Reggio PH; Rice ME
    Neurochem Int; 2008 Jan; 52(1-2):80-8. PubMed ID: 17767979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
    Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
    J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
    Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
    J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
    Monory K; Blaudzun H; Massa F; Kaiser N; Lemberger T; Schütz G; Wotjak CT; Lutz B; Marsicano G
    PLoS Biol; 2007 Oct; 5(10):e269. PubMed ID: 17927447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
    Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
    Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
    Roloff AM; Thayer SA
    Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.